# Agensys

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/agensys

- Industry: Biotechnology
- Headquarters: Santa Monica, US
- Website: www.agensys.com
- Total disclosed funding: $84M
- Latest round: Series D (Jul 12, 2007)
- Investors on record: 13

## About

Founded in 1997, Agensys is based in Santa Monica, US and is a biotechnology company, engaged in the research and development of therapeutic human monoclonal antibodies and antibody drug conjugates for the treatment of cancer.

## Funding rounds

- Series D, Jul 12, 2007, $41M — Alta Partners, OrbiMed Advisors, HBM Partners, Tekla Capital Management, Lombard Odier Asset Management, Icon Ventures, Nextech, Bear Stearns Health Innoventures, Innovis Investment Partners, Duquesne Capital Management
- Series C, Mar 1, 2002, $43M — Alta Partners, OrbiMed Advisors, HBM Partners, Tekla Capital Management, BSI Group, Bear Stearns Health Innoventures, Carnegie Kapitalforvaltning, ReqMed Company, Ltd.

## Investors

- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series C, Series D
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series C, Series D
- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series C, Series D
- Tekla Capital Management (https://capitalatlas.ai/funds/tekla-capital-management) — Series C, Series D
- BSI Group — Series C
- Bear Stearns Health Innoventures (https://capitalatlas.ai/funds/bear-stearns-health-innoventures) — Series C, Series D
- Carnegie Kapitalforvaltning — Series C
- ReqMed Company, Ltd. — Series C
- Lombard Odier Asset Management — Series D
- Icon Ventures (https://capitalatlas.ai/funds/icon-ventures) — Series D
- Nextech (https://capitalatlas.ai/funds/nextech) — Series D
- Innovis Investment Partners — Series D
- Duquesne Capital Management — Series D